UK Biotech Funding Rounds 2026
Every UK Biotech funding round filed in 2026, sourced direct from Companies House filings. Updated weekly.
UK Biotech Funding Rounds 2026
| Company | Raised | Round | Date |
|---|---|---|---|
| Watercress Research | £50k | - | 2026/06/02 |
| Loqus23 Therapeutics | £15.0M | Series A | 2026/06/02 |
| Antiverse | £3.0M | Series A | 2026/05/28 |
| Sling Therapeutics Uk | Undisclosed | - | 2026/05/27 |
| Optigenomics | £200k | - | 2026/05/26 |
| Enara Bio | £68k | - | 2026/05/22 |
| Osler Diagnostics | £1.6M | - | 2026/05/21 |
| Mykor | £2.7M | Seed | 2026/05/21 |
| Duke Street Bio | £10.8M | - | 2026/05/20 |
| Refeyn | £56k | - | 2026/05/19 |
| Camgene Therapeutics | £260k | Series A | 2026/05/17 |
| Spirea | £195k | - | 2026/05/15 |
| Cytospire Therapeutics | £3.4M | Series A | 2026/05/15 |
| Better Origin Holdings | £350k | - | 2026/05/14 |
| Testavec | £73k | - | 2026/05/14 |
| Fuse Diagnostics | £100k | - | 2026/05/13 |
| Kalvotech | £70k | - | 2026/05/13 |
| Mursla | £150k | - | 2026/05/13 |
| Demeter Bio | £27k | - | 2026/05/12 |
| Immutrin | £19.5M | Series A | 2026/05/12 |
| 113 Botanicals | £220k | - | 2026/05/12 |
| Envision Pharma Group | £614k | - | 2026/05/12 |
| Gylden Pharma | £211k | - | 2026/05/12 |
| Draig Therapeutics | £34.6M | Series A | 2026/05/11 |
| Signacor Therapeutics | £1.1M | - | 2026/05/11 |